News

News

presentation
BioSim visits mAbxience biosimilar production plant

4/11/2017

BioSim visits mAbxience biosimilar production plant

On April 5th we received in our plant in León the visit of a wide representation of the members of BioSim and the team of the association, [...]

+
mAbxience, European success accelerating global growth

2/13/2017

mAbxience, European success accelerating global growth

mAbxience is proud to announce that it has recently received the GMP Certification from the Spanish Agency of Medicines and Health Products (AEMPS), one of the strictest [...]

+
mAbxience, present in the World Biosimilar Congress Europe 2016

11/23/2016

mAbxience, present in the World Biosimilar Congress Europe 2016

Last week mAbxience took part in one of the landmark events of the biosimilar sector, the World Biosimilar Congress Europe 2016, held on 14th and 15th November [...]

+
mAbxience, winner of the Biosimilar Initiative of the Year Award 2016

10/6/2016

mAbxience, winner of the Biosimilar Initiative of the Year Award 2016

mAbxience received the Biosimilar Initiative of the Year  award at the “Global Generics & Biosimilars” ceremony held on 4th October by the prestigious British "Generics Bulletin" in Barcelona, [...]

+
Another participation in the CPhI

9/29/2016

Another participation in the CPhI

mAbxience will participate for a second consecutive year in the industrial excellence fair, the CPhI, which will celebrate its next event from 4 to 6 October in [...]

+
Biosimilars in Europe - Protagonist of BioSpain 2016

9/29/2016

Biosimilars in Europe - Protagonist of BioSpain 2016

What are the short- and medium-term prospects and opportunities for biosimilars? A round table, organised by the biotechnology company mAbxience, which specialises in the development of biosimilars, [...]

+
mAbxience at the Congress of the Spanish Society for Microbiology

9/26/2016

mAbxience at the Congress of the Spanish Society for Microbiology

The 6th Congress of Industrial Microbiology and Microbial Biotechnology, which was sponsored by the Spanish Society for Microbiology (SEM), was held at the University of León from [...]

+
6 out of 10 Doctors have already prescribed Biosimilar Medicines, according to EuropaBio Paper

9/9/2016

6 out of 10 Doctors have already prescribed Biosimilar Medicines, according to EuropaBio Paper

88,6% of doctors know what biosimilar medicines are and 59% have already prescribed biosimilar medicines as a high quality treatment for their patients, according to EuropaBio paper [...]

+
mAbxience attends the Annual Congress of Biotecnology: a day with future biotechnologists

8/2/2016

mAbxience attends the Annual Congress of Biotecnology: a day with future biotechnologists

On 13 July, the director of the mAbxience plant in León, Luisa Amoedo, led a Biomentoring session as part of the Annual Congress of Biotech¬nology (BAC), one [...]

+
mAbxience attends the event ‘Science to Business: Successful case studies in the development of innovators and biosimilars’

5/27/2016

mAbxience attends the event ‘Science to Business: Successful case studies in the development of innovators and biosimilars’

On 24 May, Azierta, a consultancy firm specialising in science and health, organised the ‘Science to Business: Successful case studies in the development of innovators and biosimilars’ [...]

+